摘要:
Nouveaux composés de triazolinone, de triazolinethione et de triazolinimine substitués, de la formule (I), utiles en tant qu'antagonistes de l'angiotensine II.
摘要:
Compounds of formula (I) wherein X is selected from CH2 or O; provided that when R?1 and R3¿ are both simultaneously hydrogen then (a) R8 is C¿1-5? alkyl or halogen, and R?2¿ is C¿1-5? alkoxy, or (b) R?4¿ is (II); and the pharmaceutically acceptable salts thereof. Such compounds are useful in mammals as oxytocin receptor antagonists for the treatment of preterm labor, dysmenorrhea and stopping labor prior to cesarean delivery.
摘要:
The invention encompasses the novel compound of formula (I) as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of formula (I). The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of formula (I).
摘要:
There is disclosed a child resistant blister package comprising a conventional blister package (10) having cavities (12) containing unit doses of medication. The blister package is adapted to receive a locking member (22) which is slidably secured to the blister package (10) to effectively prevent children from accessing the medication therein and yet is readily, slidably removed from the blister package (10) by an adult to access medication therefrom.
摘要:
A regioselective process for synthesizing any enantiomer of cis-1-amino-2-indanol, or mixture of said enantiomers, from 1,2-indane diol, or 2-halo-1-indanol wherein the process comprises the steps of (a) mixing one equivalent of 1,2-indane diol in a solvent, said solvent selected from an alkyl nitrile or aryl nitrile; (b) adding to the mixture at least about 1,5 equivalents of an acid, said acid selected from a strong protic acid or a Lewis acid or an organic acid, and maintaining thereafter the temperature of the resulting mixture between about -70 °C and about 30 °C for a time period of between about 0.25 hours to about 6.0 hours; and (c) adding excess water to effect hydrolysis, and stirring for a time period of between about 0.5 hour and about 8.0 hours, at a temperature of between about 25 °C and about 80 °C, to give substantially cis-1-amino-2-indanol.
摘要:
Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.